As of 3:59pm ET
| -0.01 / -0.49%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 6.00, with a high estimate of 11.00 and a low estimate of 5.00. The median estimate represents a +197.03% increase from the last price of 2.02.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.